BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31409487)

  • 1. Comparing risk stratification criteria for predicting lymphatic dissemination in endometrial cancer.
    Kilts TP; Glaser GE; Langstraat CL; Kumar A; Weaver AL; Mc Gree ME; Gostout BS; Podratz KC; Dowdy SC; Cliby WA; Mariani A; Bakkum-Gamez JN
    Gynecol Oncol; 2019 Oct; 155(1):21-26. PubMed ID: 31409487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor diameter as a predictor of lymphatic dissemination in endometrioid endometrial cancer.
    Cox Bauer CM; Greer DM; Kram JJF; Kamelle SA
    Gynecol Oncol; 2016 May; 141(2):199-205. PubMed ID: 26905210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of three different risk-stratification models for predicting lymph node involvement in endometrioid endometrial cancer clinically confined to the uterus.
    Korkmaz V; Meydanli MM; Yalçın I; Sarı ME; Sahin H; Kocaman E; Haberal A; Dursun P; Güngör T; Ayhan A
    J Gynecol Oncol; 2017 Nov; 28(6):e78. PubMed ID: 29027396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of a sentinel lymph node mapping algorithm and comprehensive lymphadenectomy in the detection of stage IIIC endometrial carcinoma at higher risk for nodal disease.
    Ducie JA; Eriksson AGZ; Ali N; McGree ME; Weaver AL; Bogani G; Cliby WA; Dowdy SC; Bakkum-Gamez JN; Soslow RA; Keeney GL; Abu-Rustum NR; Mariani A; Leitao MM
    Gynecol Oncol; 2017 Dec; 147(3):541-548. PubMed ID: 28965698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphadenectomy in Early-Stage Intermediate-/High-Risk Endometrioid Endometrial Cancer: Clinical Characteristics and Outcomes in an Australian Cohort.
    Farrell R; Dixon SC; Carter J; Webb PM
    Int J Gynecol Cancer; 2017 Sep; 27(7):1379-1386. PubMed ID: 30814240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of lymphatic dissemination in endometrioid endometrial cancer: Comparison of three risk-stratification models in a single-institution cohort.
    Tuomi T; Pasanen A; Leminen A; Bützow R; Loukovaara M
    Gynecol Oncol; 2017 Mar; 144(3):510-514. PubMed ID: 28069268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Mayo and Milwaukee Risk Stratification Models for Predicting Lymph Node Metastasis in Endometrial Cancer.
    Boyraz G; Atalay FO; Salman MC; Usubutun A; Erturk A; Gultekin M; Ozgul N; Yuce K
    Int J Gynecol Cancer; 2018 Jun; 28(5):869-874. PubMed ID: 29557824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel lymph nodes (SLN) in endometrial cancer: The relationship between primary tumor histology, SLN metastasis size, and non-sentinel node metastasis.
    Kennard JA; Stephens AJ; Ahmad S; Zhu X; Singh C; McKenzie ND; Kendrick JE; Holloway RW
    Gynecol Oncol; 2019 Jul; 154(1):53-59. PubMed ID: 31027899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk-scoring system for the individualized prediction of lymphatic dissemination in patients with endometrioid endometrial cancer.
    AlHilli MM; Podratz KC; Dowdy SC; Bakkum-Gamez JN; Weaver AL; McGree ME; Keeney GL; Cliby WA; Mariani A
    Gynecol Oncol; 2013 Oct; 131(1):103-8. PubMed ID: 23845691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphovascular space invasion and positive pelvic lymph nodes are independent risk factors for para-aortic nodal metastasis in endometrioid endometrial cancer.
    Solmaz U; Mat E; Dereli ML; Turan V; Tosun G; Dogan A; Sanci M; Ozdemir IA; Pala EE
    Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():63-7. PubMed ID: 25638600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphovascular space invasion and cervical stromal invasion are independent risk factors for nodal metastasis in endometrioid endometrial cancer.
    Solmaz U; Mat E; Dereli M; Turan V; Gungorduk K; Hasdemir P; Tosun G; Dogan A; Ozdemir A; Adiyeke M; Sanci M
    Aust N Z J Obstet Gynaecol; 2015 Feb; 55(1):81-6. PubMed ID: 25688821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival impact based on the thoroughness of pelvic lymphadenectomy in intermediate- or high-risk groups of endometrioid-type endometrial cancer: A multi-center retrospective cohort analysis.
    Kim TH; Kim HS; Kim TJ; Chang SJ; Kim DY; Ryu SY; Kim BG; Kim YT; Bae DS; Ryu HS; Nam JH
    Gynecol Oncol; 2016 Jun; 141(3):440-446. PubMed ID: 27020700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasion.
    Zahl Eriksson AG; Ducie J; Ali N; McGree ME; Weaver AL; Bogani G; Cliby WA; Dowdy SC; Bakkum-Gamez JN; Abu-Rustum NR; Mariani A; Leitao MM
    Gynecol Oncol; 2016 Mar; 140(3):394-9. PubMed ID: 26747778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph node metastasis probability in young patients eligible for conservative management of endometrial cancer.
    Gonthier C; Douhnai D; Koskas M
    Gynecol Oncol; 2020 Apr; 157(1):131-135. PubMed ID: 32139150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel multivariable prediction model for lymphatic dissemination in endometrioid endometrial cancer: The lymph node Metastasis Risk Index.
    Meydanli MM; Aslan K; Oz M; Muftuoglu KH; Yalcin I; Engin-Ustun Y
    Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():310-315. PubMed ID: 31377459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic significance of aortic lymph node metastasis in endometrial cancer: Potential implications for selective aortic lymph node assessment.
    Cosgrove CM; Cohn DE; Rhoades J; Felix AS
    Gynecol Oncol; 2019 Jun; 153(3):505-510. PubMed ID: 30935714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphadenectomy and prognosis for elderly females with stage I endometrioid endometrial cancer.
    Zhao L; Li L; Ye Y; Han X; Fu X; Yu Y; Luo J
    Arch Gynecol Obstet; 2019 Sep; 300(3):683-691. PubMed ID: 31256231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymph node assessment at the time of hysterectomy has limited clinical utility for patients with pre-cancerous endometrial lesions.
    Sullivan MW; Philp L; Kanbergs AN; Safdar N; Oliva E; Bregar A; Del Carmen MG; Eisenhauer EL; Goodman A; Muto M; Sisodia RC; Growdon WB
    Gynecol Oncol; 2021 Sep; 162(3):613-618. PubMed ID: 34247769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact on survival of two different staging strategies in apparent early stage endometrial cancer comparing sentinel lymph nodes mapping algorithm and selective lymphadenectomy: An Italian retrospective analysis of two reference centers.
    Buda A; Di Martino G; Restaino S; De Ponti E; Monterossi G; Giuliani D; Ercoli A; Dell'Orto F; Dinoi G; Grassi T; Scambia G; Fanfani F
    Gynecol Oncol; 2017 Dec; 147(3):528-534. PubMed ID: 29032824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New criteria for the omission of lymphadenectomy in endometrioid carcinoma.
    Matsushita C; Fujiwara H; Takei Y; Saga Y; Machida S; Taneichi A; Takahashi S; Yoshiba T; Koyanagi T; Takahashi Y; Morisawa H; Suzuki M
    Int J Gynecol Cancer; 2019 Mar; 29(3):541-546. PubMed ID: 30630888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.